newsfilter
← Latest News
GlobeNewswire·

Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected

LEXINGTON, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the joint steering committee